We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current ABEO market cap is 239.09M. The company's latest EPS is USD -1.2465 and P/E is -4.40.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 1.07M | 0 | 0 | 0 |
| Operating Income | -11.33M | -12.14M | -14.33M | -17.86M | -15.35M |
| Net Income | -11.84M | -16.59M | -31.58M | 7.41M | -30.27M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 10M | 3M | 1.41M | 4.57M |
| Operating Income | -77.09M | -81.42M | -89.84M | -47.77M | -47.14M |
| Net Income | -76.28M | -84.23M | -84.94M | -43.48M | -54.19M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 66.09M | 64M | 74.83M | 134M | 120.59M |
| Total Liabilities | 44.05M | 49.18M | 83.71M | 60.76M | 74.82M |
| Total Equity | 22.04M | 14.83M | -8.88M | 73.24M | 45.77M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 223.38M | 151.2M | 79.59M | 64.21M | 64M |
| Total Liabilities | 44.95M | 48.65M | 28.21M | 37.45M | 49.18M |
| Total Equity | 178.43M | 102.55M | 51.38M | 26.76M | 14.83M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -27.77M | -37.01M | -14.54M | -27.27M | -39.46M |
| Investing | -11.32M | 208k | -7.82M | -51.95M | -58.12M |
| Financing | 29.59M | 37.06M | 25.44M | 99.12M | 98.83M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -62.82M | -35.02M | -65.67M | -43.48M | -37.01M |
| Investing | 59.98M | -83.71M | 66.06M | -23.96M | 208k |
| Financing | 113.9M | 1.94M | 24.86M | 43.17M | 37.06M |
| Market Cap | 239.09M |
| Price to Earnings Ratio | -4.40 |
| Price to Sales Ratio | 52.29 |
| Price to Cash Ratio | 16.49 |
| Price to Book Ratio | 16.1 |
| Dividend Yield | - |
| Shares Outstanding | 43.47M |
| Average Volume (1 week) | 210.24k |
| Average Volume (1 Month) | 264.79k |
| 52 Week Change | -21.43% |
| 52 Week High | 9.01 |
| 52 Week Low | 3.05 |
| Spread (Intraday) | 0.06 (1.08%) |
| Company Name | Abeona Therapeutics Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.abeonatherapeutics.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
